Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Use of the Long-acting Hematopoietic Growth Factors Pegfilgrastim and Darbepoetin Alfa in Support of Dose-Dense Adjuvant Chemotherapy

Burstein HJ, Parker LM, Doherty J, Partridge AH, Schapira L, Ryan PD, Younger J, Harris LN, Moy B, Bunnell CA, Come S, Schumer S, Haldoupis M, Gelman R, Winer EP. Use of the Long-acting Hematopoietic Growth Factors Pegfilgrastim and Darbepoetin Alfa in Support of Dose-Dense Adjuvant Chemotherapy. San Antonio Breast Cancer Symposium. 2004.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.